Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Guillem Argilés, Mark P. Saunders, Fernando Rivera, Alberto Sobrero, Al Benson, Carmen Guillén Ponce, Stefano Cascinu, Eric Van Cutsem, Iain R. MacPherson, Dirk Strumberg, Claus Henning Köhne, John Zalcberg, Andrea Wagner, Vittorio Luigi Garosi, Julia Grunert, Josep Tabernero, Fortunato Ciardiello*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science